Reducing Operative and Post-operative Morbidity in Living Kidney Donors With the Airseal System
1 other identifier
interventional
41
1 country
1
Brief Summary
The purpose of this study is to determine if the Airseal System will reduce post-operative pain and reduce the need for narcotics in laparoscopic living kidney donor surgeries.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable pain
Started Aug 2014
Typical duration for not_applicable pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 9, 2014
CompletedStudy Start
First participant enrolled
August 1, 2014
CompletedFirst Posted
Study publicly available on registry
October 10, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2016
CompletedResults Posted
Study results publicly available
December 23, 2016
CompletedJanuary 17, 2018
January 1, 2018
1.3 years
July 9, 2014
September 8, 2016
January 12, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Narcotic Use (mg)
Total Morphine Equivalents - mean in mg
Intra-Operative on day of surgery
Narcotic Use (mg)
Total Morphine Equivalents - mean in mg
Post-operative (until time of discharge, typically 2-4 days)
Narcotic Use (mg)
Total Morphine Equivalent - mean in mg
Operative and Post-operative (until time of discharge, typically 2-4 days)
Secondary Outcomes (4)
Subjective Pain Score
1 hour post-op
Subjective Pain Score
6 hours post-op
Subjective Pain Score
12 hours post-op
Mean ETCO2
intraoperative
Study Arms (2)
Conventional Pressure
ACTIVE COMPARATORConventional Insufflation with 15mmHg target pressure
Low Pressure (VTI)
EXPERIMENTALValveless recirculating insufflation (VTI) with 10mmHg target pressure
Interventions
Eligibility Criteria
You may qualify if:
- Any living donor who has been approved to donate a kidney is eligible to participate.
You may not qualify if:
- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yale Universitylead
- SurgiQuest, Inc.collaborator
Study Sites (1)
Yale New Haven Transplantation Center
New Haven, Connecticut, 06520, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Sanjay Kulkarni
- Organization
- Yale University
Study Officials
- STUDY DIRECTOR
Sanjay Kulkarni, MD
Yale University
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- LTE60
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 9, 2014
First Posted
October 10, 2014
Study Start
August 1, 2014
Primary Completion
December 1, 2015
Study Completion
February 1, 2016
Last Updated
January 17, 2018
Results First Posted
December 23, 2016
Record last verified: 2018-01